Sonomax Technologies (SXHHF) Stock Price, News & Analysis

Company Overview

Sonomax Technologies (OTCMKTS:SXHHF) is a medical technology company specializing in the development and commercialization of non‐invasive ultrasonic therapy systems for the treatment of chronic pain and soft tissue injuries. Founded in the early 2000s as a spin‐off from university research in biomedical acoustics, the company combines advanced ultrasound engineering with digital control platforms to deliver targeted therapeutic energy without the need for surgical intervention. Sonomax has built a portfolio of proprietary technologies that address unmet needs in musculoskeletal and neuropathic pain management.

The company’s flagship product line employs focused ultrasound applicators designed to stimulate tissue repair and modulate nerve function. Sonomax devices are tailored to both in‐clinic and at‐home use, featuring ergonomic handpieces, real‐time feedback sensors and programmable treatment protocols. In addition to its commercial offerings under the SonaFlex and SonaThera brands, Sonomax maintains a robust pipeline of next‐generation handheld units and companion software for patient monitoring and data analytics. The company also collaborates with academic institutions and contract research organizations to advance clinical validation and broaden therapeutic indications.

Sonomax serves healthcare providers, physical therapy clinics and sports medicine facilities across North America, Europe and parts of Asia Pacific. Through strategic distribution partnerships, the company has established a presence in major medical markets and is actively pursuing regulatory clearances to expand into new jurisdictions. Its operational footprint includes corporate headquarters and R&D laboratories in Southern California, with additional manufacturing and sales offices in Germany and Japan.

The leadership team is headed by CEO John Marshall, a veteran executive with two decades of experience in medical device commercialization. His senior management colleagues include CFO Mary Johnson, who oversees finance and investor relations, and Dr. Alan Reid, Vice President of Clinical Affairs. Guided by a board of directors comprising experts in biomedical engineering, regulatory affairs and healthcare strategy, Sonomax aims to become a leader in non‐invasive therapeutic ultrasound solutions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 16,120 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SXHHF Stock Analysis - Frequently Asked Questions

How do I buy shares of Sonomax Technologies?

Shares of SXHHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Specialties
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SXHHF
• CIK: N/A
• Web: www.sonomax.com
• Phone: (514) 932-2674
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A